Identification of genes whose expression is altered during mitosuppression in livers of ethinyl estradiol-treated female rats.
In this study, our goal was to identify genes whose expression in liver is altered in female F-344 rats during mitosuppression induced by 42 days of ethinyl estradiol (EE) treatment (Yager et al., Carcinogenesis, 15, 2117-2123, 1994). Northern analysis demonstrated that the mRNA levels for transforming growth factor-beta1 (TGF-beta1) and the mannose 6-phosphate/insulin-like growth factor II receptor were significantly increased by EE treatment. Ten cDNA clones representing mRNAs whose expression was increased two- to four-fold in the mitosuppressed livers were identified by differential display. Sequence analysis revealed that one was homologous to the S-24 ribosomal protein and another to mitochondrial ATPase subunit e. The remaining clones showed no homology to known genes in GenBank. However, the expression of clones 15, 16 and 17 was increased in HepG2 cells following treatment with doxorubicin suggesting their induction by oxidative DNA damage. These results suggest that two independent but interrelated signalling pathways, one mediated through transforming growth factor-beta and the other through oxidative DNA damage, may contribute to hepatic mitosuppression caused by EE, perhaps through activation of cyclin-dependent kinase inhibitors.
Chen
J
J
Johns Hopkins University, The School of Hygiene and Public Health, Baltimore, MD 21205-2179, USA.
Schwartz
D A
DA
Young
T A
TA
Norris
J S
JS
Yager
J D
JD
D000818:Animals; D004997:Ethinyl Estradiol / Q000633:toxicity*; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects*; D008099:Liver / Q000187:drug effects*; D051381:Rats; D011916:Rats, Inbred F344; D017527:Receptor, IGF Type 2 / Q000235:genetics; D016212:Transforming Growth Factor beta / Q000235:genetics
D017527:Receptor, IGF Type 2; D016212:Transforming Growth Factor beta; D004997:Ethinyl Estradiol